SEC Filing

Investor Contacts

Katherine A. Littrell, PhD, RN
Vice President, Investor Relations

Diane H. Schrick
Senior Director, Investor Relations

investorinfo@jazzpharma.com
Ireland: +353 1 634 7892
U.S.: +1 650 496 2800

SEC Filing Details

Document Details

Filing Date
Feb 11, 2019
Document Date
Feb 11, 2019
Form Description
A statement of beneficial ownership of common stock by certain persons
Filing Group
3,4,5
Company
Jazz Pharmaceuticals plc
Issuer
JAZZ PHARMACEUTICALS INC